# First Clinic Launch Status

**Authoritative source of truth**  
**Updated:** 2026-09-07T02:57:49Z (Phase 6C)  
**Evidence:**  
- `docs/testing/phase-6a-first-clinic-launch-gate-reconciliation.json`  
- `docs/testing/phase-6b-auth-invite-redirect-remediation.json`  
- `docs/testing/phase-6b2-real-staff-invitation-closeout.json`  
- `docs/testing/phase-6c-privacy-data-flow-audit.json`  
- `docs/privacy/PRIVACY_DATA_FLOW_ARCHITECTURE.md`

This document supersedes stale checklist wording where later production evidence proves otherwise. It does **not** reopen locked workstreams or Anti-Wrinkle pathway work.

---

## Executive answer

| Question | Answer |
|----------|--------|
| Can Scott start **selling / demoing**? | **YES** |
| Can Scott **create / onboard a clinic account** (Scott as sole admin)? | **YES** |
| Can Scott **invite additional clinic staff** via Staff Directory? | **YES** |
| Can Scott **enrol the first real patient**? | **NO** — blocked by **EXT-002** until privacy/legal launch pack is completed |

**Anti-Wrinkle pathway:** CLOSED — production ready for future enrolments on **v6** (after EXT-002).

**AUTH-INVITE-REDIRECT:** **CLOSED — PROVEN IN REAL PRODUCTION** (Phase 6B fix + Phase 6B2 acceptance).

**EXT-002 Privacy / Terms / patient privacy architecture:** **OPEN — BLOCKER BEFORE FIRST REAL PATIENT**  
Reason: Privacy/legal framework being completed from verified production data-flow architecture (Phase 6C).

---

## What is done (CLOSED — PROVEN)

- Workstreams **A–H** permanently locked (PASS)
- Security / AuthZ production attack matrix **25/25** (Workstream H)
- Consent / Start Monitoring gate (LAUNCH-001)
- Dead Terms/Privacy `#` links removed (LAUNCH-002 software)
- First-clinic runbook exists and path-verified
- Clinic configuration, protocol adopt, patient journey (controlled production)
- Anti-Wrinkle **v6** global + Test Aesthetics adoption (Phase 5M)
- Password recovery 5J8A–C PASS
- **LAUNCH-003** SMTP CLOSED (5J8A–C; reconfirmed by real invitation email delivery)
- **AUTH-INVITE-REDIRECT** CLOSED — code remediations in 6B + real Staff Directory invitation accepted in production (6B2)
- **Phase 6C** privacy/data-flow architecture audit PASS (factual map only; no legal drafting)
- Sydney healthy; Mumbai rollback-only; media/notifications flags fail-closed

---

## Stale items (CLOSE)

| Gate | Why stale |
|------|-----------|
| **LAUNCH-003** SMTP mailbox proof | Proven via Zoho recovery + real invitation email |
| Phase 5M / 6A “next = LAUNCH-003” | Superseded |
| Phase 6B “live invitation proof pending” | Completed in 6B2 |
| Optional residual invite smoke after redirect fix | Satisfied by 6B2 real acceptance |
| Prior EXT-002 wording as soft “if legal require” only | Superseded by Phase 6C: treated as **blocker before first real patient** |

---

## True remaining gates

### 1. EXT-002 Privacy / Terms / patient privacy architecture — OPEN — BLOCKER BEFORE FIRST REAL PATIENT

**Current state:** Phase 6C factual architecture complete. Hosted Privacy/Terms documents and legal pack **not yet drafted**. Software omits legal links unless https env URLs are set (LAUNCH-002 CLOSED).

| Stage | Blocks? |
|-------|---------|
| Sales / demo | **NO** |
| Clinic onboarding | **NO** |
| Staff invitation | **NO** |
| First real patient health information in SignalCare | **YES** |

**Missing for close:** counsel/founder privacy/legal launch pack (and any required hosted documents / operational processes) based on Phase 6C evidence — not further product engineering by default.

### 2. EXT-001 Formal external clinical sign-off (BL-012) — OPEN — PILOT TASK (not a software blocker)

SignalCare pathway governance is: authoritative evidence + conservative safety policy + internal clinical rationale + founder approval + immutable versioning + controlled production validation + structured real-world clinician feedback.

External clinician feedback is useful; it is **not** an automatic prerequisite or veto for each pathway. Anti-Wrinkle already has controlled live validation + founder-approved v6. Treat EXT-001 as optional pilot feedback, not a hard launch gate unless Scott elects otherwise.

### 3. EXT-003 Regulatory / insurance / corporate — OPEN — PILOT TASK / counsel

Outside engineering. Not evidenced as a product software blocker. Resolve with counsel as needed for the commercial pilot (corporate entity, insurance/cyber cover, privacy governance, customer terms) — do not invent requirements here.

---

## Deferred (not first-clinic blockers)

Stripe production activation · patient media/MMS · external clinician notifications · Slack/Teams · native apps · advanced analytics · org-wide CQ/reports · dental/surgical expansion · enabling OpenAI semantic intent in ECS (requires legal review per Phase 6C).

---

## What Scott can do now

1. Sell and demo SignalCare.
2. Provision real aesthetics clinics (runbook).
3. Invite clinic staff via Staff Directory (production invitation flow proven).
4. **Do not** enrol the first real patient’s health information until EXT-002 privacy/legal pack is completed.
5. Optionally deactivate the Phase 6B2 controlled test staff membership after evidence closeout (do not delete audit history).

---

## Single next action

**Use the verified Phase 6C architecture and current Australian legal requirements to prepare SignalCare’s privacy/legal launch pack.**

---

## Production snapshot (6C)

| Check | Result |
|-------|--------|
| API health | ok |
| API build (ECS env) | `f1de2d9…` |
| ECS task | `signalcare-api:221` |
| Web | HTTP 200 (unchanged; docs-only phase) |
| Sydney | `kfwfcgfirsdpqpiiemaq` |
| Mumbai | untouched |
| Flags | media/notifications `false` |
| OpenAI in ECS task | **not injected** (secrets exist unmounted) |

---

## Test clinic / patients

Test Aesthetics + controlled patients remain isolated. Do not delete historical controlled patients. Phase 6B2 invited staff account may be deactivated via Staff Directory when convenient.
